Related Experiment Video
Updated: Apr 13, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
p47phox-Nox2-dependent ROS Signaling Inhibits Early Bone Development in Mice but Protects against Skeletal Aging
Jin-Ran Chen1, Oxana P Lazarenko2, Michael L Blackburn2
1From the Arkansas Children's Nutrition Center and the Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72202 chenjinran@uams.edu.
Abstract:
Bone remodeling is age-dependently regulated and changes dramatically during the course of development. Progressive accumulation of reactive oxygen species (ROS) has been suspected to be the leading cause of many inflammatory and degenerative diseases, as well as an important factor underlying many effects of aging. In contrast, how reduced ROS signaling regulates inflammation and remodeling in bone remains unknown. Here, we utilized a p47(phox) knock-out mouse model, in which an essential cytosolic co-activator of Nox2 is lost, to characterize bone metabolism at 6 weeks and 2 years of age. Compared with their age-matched wild type controls, loss of Nox2 function in p47(phox-/-) mice resulted in age-related switch of bone mass and strength. Differences in bone mass were associated with increased bone formation in 6-week-old p47(phox-/-) mice but decreased in 2-year-old p47(phox-/-) mice. Despite decreases in ROS generation in bone marrow cells and p47(phox)-Nox2 signaling in osteoblastic cells, 2-year-old p47(phox-/-) mice showed increased senescence-associated secretory phenotype in bone compared with their wild type controls. These in vivo findings were mechanistically recapitulated in ex vivo cell culture of primary fetal calvarial cells from p47(phox-/-) mice. These cells showed accelerated cell senescence pathway accompanied by increased inflammation. These data indicate that the observed age-related switch of bone mass in p47(phox)-deficient mice occurs through an increased inflammatory milieu in bone and that p47(phox)-Nox2-dependent physiological ROS signaling suppresses inflammation in aging.
Insights
Reduced reactive oxygen species (ROS) signaling in p47(phox-/-) mice leads to age-related bone loss. This occurs through increased inflammation and senescence, indicating ROS signaling suppresses aging-related bone inflammation.
Area of Science:
- Bone Biology
- Aging Research
- Inflammation
Background:
- Bone remodeling is tightly regulated by age, with aging often associated with increased reactive oxygen species (ROS).
- The role of reduced ROS signaling in bone inflammation and remodeling during aging remains largely unexplored.
- The p47(phox) protein is a crucial component of the Nox2 oxidase complex, essential for ROS production.
Purpose of the Study:
- To investigate the impact of impaired Nox2 function (loss of p47(phox)) on bone metabolism and aging.
- To elucidate the mechanisms by which reduced ROS signaling affects bone remodeling, inflammation, and senescence.
- To determine if physiological ROS signaling plays a protective role against age-related bone changes.
Main Methods:
- Utilized p47(phox) knock-out (p47(phox-/-)) mice and age-matched wild-type controls.
- Assessed bone mass and strength at 6 weeks and 2 years of age.
- Analyzed ROS generation, p47(phox)-Nox2 signaling, senescence-associated secretory phenotype, and inflammation in vivo and in ex vivo cell cultures.
Main Results:
- p47(phox-/-) mice exhibited an age-related switch in bone mass and strength compared to controls.
- Younger p47(phox-/-) mice showed increased bone formation, while older mice displayed decreased bone mass.
- Older p47(phox-/-) mice had increased senescence and inflammation in bone, despite reduced ROS generation.
Conclusions:
- The age-related decline in bone mass in p47(phox)-deficient mice is driven by an exacerbated inflammatory environment.
- Physiological ROS signaling mediated by p47(phox)-Nox2 is critical for suppressing inflammation during aging.
- Impaired ROS production contributes to accelerated bone senescence and inflammation, highlighting a protective role of ROS in bone aging.
Related Concept Videos
Bone Remodeling and Repair
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Bone Formation by Endochondral Ossification

